Bopp Silvia, Özdemir Hüseyin Baran, Aktaş Zeynep, Khoramnia Ramin, Yildirim Timur M, Schickhardt Sonja, Auffarth Gerd U, Özdek Şengül
Capio Augenklinik Universitätsallee, 28213 Bremen, Germany.
Department of Ophthalmology, Gazi University School of Medicine, Ankara 06570, Turkey.
Diagnostics (Basel). 2023 Jun 1;13(11):1943. doi: 10.3390/diagnostics13111943.
To determine the clinical risk factors that may increase the occurrence of intraocular lens (IOL) calcification in patients who had undergone pars plana vitrectomy (PPV).
The medical records of 14 patients who underwent IOL explantation due to clinically significant IOL opacification after PPV were reviewed. The date of primary cataract surgery, technique and implanted IOL characteristics; the time, cause and technique of PPV; tamponade used; additional surgeries; the time of IOL calcification and explantation; and IOL explantation technique were investigated.
PPV had been performed as a combined procedure with cataract surgery in eight eyes and solely in six pseudophakic eyes. The IOL material was hydrophilic in six eyes, hydrophilic with a hydrophobic surface in seven eyes and undetermined in one eye. The endotamponades used during primary PPV were C2F6 in eight eyes, C3F8 in one eye, air in two eyes and silicone oil in three eyes. Two of three eyes underwent subsequent silicone oil removal and gas tamponade exchange. Gas in the anterior chamber was detected in six eyes after PPV or silicone oil removal. The mean interval between PPV and IOL opacification was 20.5 ± 18.6 months. The mean BCVA in logMAR was 0.43 ± 0.42 after PPV, which significantly decreased to 0.67 ± 0.68 before IOL explantation for IOL opacification ( = 0.007) and increased to 0.48 ± 0.59 after the IOL exchange ( = 0.015).
PPV with endotamponades in pseudophakic eyes, particularly gas, seems to increase the risk for secondary IOL calcification, especially in hydrophilic IOLs. IOL exchange seems to solve this problem when clinically significant vision loss occurs.
确定在接受玻璃体切割术(PPV)的患者中可能增加人工晶状体(IOL)钙化发生率的临床危险因素。
回顾了14例因PPV术后具有临床意义的IOL混浊而接受IOL取出术的患者的病历。调查了初次白内障手术的日期、技术和植入的IOL特征;PPV的时间、原因和技术;使用的填塞物;额外的手术;IOL钙化和取出的时间;以及IOL取出技术。
8只眼的PPV是与白内障手术联合进行的,6只假晶状体眼单独进行了PPV。IOL材料在6只眼中为亲水性,7只眼中为具有疏水表面的亲水性,1只眼中未确定。初次PPV期间使用的内填塞物在8只眼中为C2F6,1只眼中为C3F8,2只眼中为空气,3只眼中为硅油。3只眼中的2只随后进行了硅油取出和气体填塞物交换。PPV或硅油取出后,6只眼中检测到前房有气体。PPV与IOL混浊之间的平均间隔时间为20.5±18.6个月。PPV后logMAR的平均最佳矫正视力(BCVA)为0.43±0.42,在因IOL混浊进行IOL取出术前显著降至0.67±0.68(P = 0.007),IOL置换后增至0.48±0.59(P = 0.015)。
假晶状体眼中使用内填塞物(尤其是气体)的PPV似乎会增加继发性IOL钙化的风险,尤其是在亲水性IOL中。当发生具有临床意义的视力丧失时,IOL置换似乎可以解决这个问题。